Table 1

Comparison between patients (with stroke) and controls (without stroke) for patients without diabetes: phase I

VariablesPatients (with stroke) (n=233)Controls (healthy matches) (n=245)p Value
Age (years)54.69±1.6050.33±1.440.96
Gender/sex (males) n (%)133 (57.08)130 (53.06)0.31
Gender/sex (females) n (%)100 (42.91)115 (46.93)
BSF (mg/dL)112.43±5.7698.7±8.980.84
HbA1c (%)5.93±2.975.57±1.650.03
HDL-C (mg/dL)43.00±1.9546.54±2.430.02
LDL-C (mg/dL)96.40±7.9687.78±9.830.07
TGL-C (mg/dL)221±37.89176±27.890.00
TC (mg/dL)178.50±27.66169.76±26.760.21
SBP (mm Hg)147.63±35.64126.78±23.340.04
DBP (mm Hg)90.56±16.6481.24±8.900.04
BMI (kg/m2)24.23±2.3423.95±2.120.18
Smoking n (%)143 (61.37)52 (21.22)0.02
  • Bold indicates significant p Values. Comparison between patients and controls for patients without diabetes: phase I: values are presented as mean±SD.

  • BMI, body mass index; BSF, blood sugar fasting; DBP, diastolic blood pressure; HbA1c, glycated haemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TGL-C, triglyceride cholesterol.